Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway

References

• ArroyoV, AngeliP, MoreauR, et al. The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J Hepatol. 2021;74(3):670–685. doi:10.1016/j.jhep.2020.11.04833301825
   PubMed Web of Science ®Google Scholar
• TrautweinC, FriedmanSL, SchuppanD, PinzaniM. Hepatic fibrosis: concept to treatment. J Hepatol. 2015;62(1):S15–S24. doi:10.1016/j.jhep.2015.02.03925920084
   PubMed Web of Science ®Google Scholar
• LozanoR, NaghaviM, ForemanK, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-023245604
   PubMed Web of Science ®Google Scholar
• SunM, KisselevaT. Reversibility of liver fibrosis. Clin Res Hepatol Gastroenterol. 2015;39(Suppl 1):S60–S63. doi:10.1016/j.clinre.2015.06.01526206574
   PubMed Web of Science ®Google Scholar
• TsuchidaT, FriedmanSL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397–411. doi:10.1038/nrgastro.2017.3828487545
   PubMed Web of Science ®Google Scholar
• HellerbrandC, StefanovicB, GiordanoF, BurchardtER, BrennerDA. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. J Hepatol. 1999;30(1):77–87. doi:10.1016/s0168-8278(99)80010-59927153
   PubMed Web of Science ®Google Scholar
• ChangSW, ShefelbineSJ, BuehlerMJ. Structural and mechanical differences between collagen homo- and heterotrimers: relevance for the molecular origin of brittle bone disease. Biophys J. 2012;102(3):640–648. doi:10.1016/j.bpj.2011.11.399922325288
   PubMed Web of Science ®Google Scholar
• MallatA, LodderJ, Teixeira-ClercF, MoreauR, CodognoP, LotersztajnS. Autophagy: a multifaceted partner in liver fibrosis. Biomed Res Int. 2014;2014:869390. doi:10.1155/2014/86939025254217
   PubMed Web of Science ®Google Scholar
• BaL, GaoJ, ChenY, et al. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways. Phytomedicine. 2019;58:152765. doi:10.1016/j.phymed.2018.11.02531005720
   PubMed Web of Science ®Google Scholar
• VarshneyP, SainiN. PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis. Biochim Biophys Acta Mol Basis Dis. 2018;1864(5):1795–1803. doi:10.1016/j.bbadis.2018.02.00329432814
   PubMed Web of Science ®Google Scholar
• WangH, LiuY, WangD, et al. The upstream pathway of mTOR-mediated autophagy in liver diseases. Cells-Basel. 2019;8(12):1597. doi:10.3390/cells8121597
   PubMed Web of Science ®Google Scholar
• ThoenLF, GuimaraesEL, DolleL, et al. A role for autophagy during hepatic stellate cell activation. J Hepatol. 2011;55(6):1353–1360. doi:10.1016/j.jhep.2011.07.01021803012
   PubMed Web of Science ®Google Scholar
• DuranA, HernandezED, Reina-CamposM, et al. p62/SQSTM1 by binding to vitamin D receptor inhibits hepatic stellate cell activity, fibrosis, and liver cancer. Cancer Cell. 2016;30(4):595–609. doi:10.1016/j.ccell.2016.09.00427728806
   PubMed Web of Science ®Google Scholar
• KimKM, HanCY, KimJY, et al. Galpha12 overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cells. J Hepatol. 2018;68(3):493–504. doi:10.1016/j.jhep.2017.10.01129080810
   PubMed Web of Science ®Google Scholar
• LingL, LiG, WangG, MengD, LiZ, ZhangC. Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis. Mol Med Rep. 2019;20(2):1605–1612. doi:10.3892/mmr.2019.1040131257490
   PubMed Web of Science ®Google Scholar
• WuY, LiZ, XiuAY, MengDX, WangSN, ZhangCQ. Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice. Drug Des Devel Ther. 2019;13:2667–2676. doi:10.2147/DDDT.S210797
   PubMed Web of Science ®Google Scholar
• MengD, LiZ, WangG, LingL, WuY, ZhangC. Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells. Biomed Pharmacother. 2018;108:1617–1627. doi:10.1016/j.biopha.2018.10.00530372864
   PubMed Web of Science ®Google Scholar
• AllaireM, RautouPE, CodognoP, LotersztajnS. Autophagy in liver diseases: time for translation?J Hepatol. 2019;70(5):985–998. doi:10.1016/j.jhep.2019.01.02630711404
   PubMed Web of Science ®Google Scholar
• ChapmanN, ChenCY, FujitaT, et al. Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension?J Hypertens. 2010;28(9):1796–1803. doi:10.1097/HJH.0b013e32833b912c20543713
   PubMed Web of Science ®Google Scholar
• FultonB, WagstaffAJ, SorkinEM. Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia. Drugs. 1995;49(2):295–320. doi:10.2165/00003495-199549020-000117537194
   PubMed Web of Science ®Google Scholar
• ShawYJ, YangYT, GarrisonJB, KyprianouN, ChenCS. Pharmacological exploitation of the alpha1-adrenoreceptor antagonist doxazosin to develop a novel class of antitumor agents that block intracellular protein kinase B/Akt activation. J Med Chem. 2004;47(18):4453–4462. doi:10.1021/jm049752k15317457
   PubMed Web of Science ®Google Scholar
• Cervantes-GarciaD, Cuellar-JuarezAG, Borrego-SotoG, et al. Adenoviralbone morphogenetic protein7 and/or doxazosin therapies promote the reversion of fibrosis/cirrhosis in a cirrhotic hamster model. Mol Med Rep. 2017;16(6):9431–9440. doi:10.3892/mmr.2017.778529039539
   PubMed Web of Science ®Google Scholar
• Serna-SalasSA, Navarro-GonzalezYD, Martinez-HernandezSL, et al. Doxazosin and carvedilol treatment improves hepatic regeneration in a hamster model of cirrhosis. Biomed Res Int. 2018;2018:4706976. doi:10.1155/2018/470697630643808
   PubMed Web of Science ®Google Scholar
• AlbillosA, LledoJL, BanaresR, et al. Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension. Hepatology. 1994;20(3):611–617.7915703
   PubMed Web of Science ®Google Scholar
• ZachariasAP, JeyarajR, HobolthL, BendtsenF, GluudLL, MorganMY. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices. Cochrane Database Syst Rev. 2018;10:D11510. doi:10.1002/14651858.CD011510.pub2
   Web of Science ®Google Scholar
• ForbesA, Anoopkumar-DukieS, Chess-WilliamsR, McDermottC. Relative cytotoxic potencies and cell death mechanisms of alpha1 -adrenoceptor antagonists in prostate cancer cell lines. Prostate. 2016;76(8):757–766. doi:10.1002/pros.2316726880388
   PubMed Web of Science ®Google Scholar
• MizushimaN, YoshimoriT, LevineB. Methods in mammalian autophagy research. Cell. 2010;140(3):313–326. doi:10.1016/j.cell.2010.01.02820144757
   PubMed Web of Science ®Google Scholar
• FengD, WangB, WangL, et al. Pre-ischemia melatonin treatment alleviated acute neuronal injury after ischemic stroke by inhibiting endoplasmic reticulum stress-dependent autophagy via PERK and IRE1 signalings. J Pineal Res. 2017;62(3):e12395. doi:10.1111/jpi.12395
   Web of Science ®Google Scholar
• Abdel-KawyHS. Effect of carvedilol versus propranolol on acute and chronic liver toxicity in rats. Drug Chem Toxicol. 2021;44(1):101–111. doi:10.1080/01480545.2019.157671830810389
   PubMed Web of Science ®Google Scholar
• PuschelGP. Control of hepatocyte metabolism by sympathetic and parasympathetic hepatic nerves. Anat Rec a Discov Mol Cell Evol Biol. 2004;280(1):854–867. doi:10.1002/ar.a.2009115382015
   PubMedGoogle Scholar
• Munoz-OrtegaMH, Llamas-RamirezRW, Romero-DelgadilloNI, et al. Doxazosin treatment attenuates carbon tetrachloride-induced liver fibrosis in hamsters through a decrease in transforming growth factor beta secretion. Gut Liver. 2016;10(1):101–108. doi:10.5009/gnl1445926573293
   PubMed Web of Science ®Google Scholar
• KostallariE, HirsovaP, PrasnickaA, et al. Hepatic stellate cell-derived platelet-derived growth factor receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2. Hepatology. 2018;68(1):333–348. doi:10.1002/hep.2980329360139
   PubMed Web of Science ®Google Scholar
• XuM, XuHH, LinY, et al. LECT2, a ligand for Tie1, plays a crucial role in liver fibrogenesis. Cell. 2019;178(6):1478–1492. doi:10.1016/j.cell.2019.07.02131474362
   PubMed Web of Science ®Google Scholar
• ZhangZ, GuoM, LiY, et al. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells. Autophagy. 2020;16(8):1482–1505. doi:10.1080/15548627.2019.168798531679460
   PubMed Web of Science ®Google Scholar
• SuzukiS, YamamotoM, SanomachiT, et al. Doxazosin, a classic alpha 1-adrenoceptor antagonist, overcomes osimertinib resistance in cancer cells via the upregulation of autophagy as drug repurposing. Biomedicines. 2020;8(8):273. doi:10.3390/biomedicines8080273
   Web of Science ®Google Scholar
• ThoenLF, GuimaraesEL, GrunsvenLA. Autophagy: a new player in hepatic stellate cell activation. Autophagy. 2012;8(1):126–128. doi:10.4161/auto.8.1.1810522082960
   PubMed Web of Science ®Google Scholar
• GaoJ, WeiB, de AssuncaoTM, et al. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis. J Hepatol. 2020;73(5):1144–1154. doi:10.1016/j.jhep.2020.04.04432389810
   PubMed Web of Science ®Google Scholar
• JiaD, WangYY, WangP, et al. SVIP alleviates CCl4-induced liver fibrosis via activating autophagy and protecting hepatocytes. Cell Death Dis. 2019;10(2):71. doi:10.1038/s41419-019-1311-030683843
   PubMed Web of Science ®Google Scholar
• GordyC, HeYW. The crosstalk between autophagy and apoptosis: where does this lead?Protein Cell. 2012;3(1):17–27. doi:10.1007/s13238-011-1127-x22314807
   PubMed Web of Science ®Google Scholar
• GarrisonJB, KyprianouN. Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway. Cancer Res. 2006;66(1):464–472. doi:10.1158/0008-5472.CAN-05-203916397262
   PubMed Web of Science ®Google Scholar
• HuiH, FernandoMA, HeaneyAP. The alpha1-adrenergic receptor antagonist doxazosin inhibits EGFR and NF-kappaB signalling to induce breast cancer cell apoptosis. Eur J Cancer. 2008;44(1):160–166. doi:10.1016/j.ejca.2007.10.00218042375
   PubMed Web of Science ®Google Scholar
• PellicoroA, RamachandranP, IredaleJP, FallowfieldJA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14(3):181–194. doi:10.1038/nri362324566915
   PubMed Web of Science ®Google Scholar
• KishoreR, KrishnamurthyP, GarikipatiVN, et al. Interleukin-10 inhibits chronic angiotensin II-induced pathological autophagy. J Mol Cell Cardiol. 2015;89(Pt B):203–213. doi:10.1016/j.yjmcc.2015.11.00426549357
   PubMed Web of Science ®Google Scholar
• CuiLH, LiCX, ZhuoYZ, YangL, CuiNQ, ZhangSK. Saikosaponin d ameliorates pancreatic fibrosis by inhibiting autophagy of pancreatic stellate cells via PI3K/Akt/mTOR pathway. Chem Biol Interact. 2019;300:18–26. doi:10.1016/j.cbi.2019.01.00530611790
   PubMed Web of Science ®Google Scholar
• HuangTJ, RenJJ, ZhangQQ, et al. IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway. Biomed Pharmacother. 2019;116:109034. doi:10.1016/j.biopha.2019.10903431152924
   PubMed Web of Science ®Google Scholar
• GuoJ, LuoX, LiangJ, XiaoM, SunX. Antiangiogenic effects of doxazosin on experimental choroidal neovascularization in mice. J Ocul Pharmacol Ther. 2017;33(1):50–56. doi:10.1089/jop.2016.015327992238
   PubMed Web of Science ®Google Scholar